Skip to content
ClinCalc Pro
Menu
Intermediate-acting Insulin

Insulin NPH (Isophane)

Brand names: Humulin I, Insulatard

Insulin NPH (isophane) is an intermediate-acting human insulin suspension used to provide basal insulin cover in type 1 and type 2 diabetes.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It acts on insulin receptors to increase glucose uptake and reduce hepatic glucose production; complexing with protamine forms a crystalline suspension that delays absorption, giving an intermediate duration with a defined peak.

Prescribing in practice

  • As a suspension with a pronounced peak, NPH carries a notable risk of hypoglycaemia, particularly overnight.
  • Resuspend gently by rolling the cloudy vial or pen before each injection to ensure a uniform, accurate dose.
  • Rotate injection sites and review timing, as the peak action can be mistimed relative to meals or sleep.

Monitoring

Monitor capillary blood glucose, including overnight or pre-breakfast values, and HbA1c to guide titration.

Counselling the patient

  • Gently mix the cloudy insulin until evenly milky before each dose.
  • Carry fast-acting glucose and be especially alert to night-time hypoglycaemia.
  • Rotate injection sites and never share pens or needles.

Evidence & guidelines

Isophane (NPH) insulin is a long-standing basal insulin option referenced in NICE diabetes guidance.

Reference: NICE NG3 (Diabetes in Pregnancy); NICE NG17 (Type 1 DM); MHRA Insulin Safety Alert; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.